An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study

Proteomics - Clinical Applications

Volumn 3, Issue 8, 2009, Pages 932-946

  Bakun, Magda ^a   Karczmarski, Jakub ^b   Poznanski, Jaroslaw ^a   Rubel, Tymon ^b,c   Rozga, Malgorzata ^a   Malinowska, Agata ^a   Sands, Dorota ^d   Hennig, Ewa ^e   Oledzki, Janusz ^b   Ostrowski, Jerzy ^b,e   Dadlez, Michal ^a,f  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^d INSTITUTE OF MOTHER AND CHILD   (Poland)

^e MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^f UNIVERSITY OF WARSAW   (Poland)

Author keywords

Absolute quantitation; MS; Plasma; Relative quantitation; Serum

Indexed keywords

PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DATA ANALYSIS; DIFFERENTIAL DIAGNOSIS; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; ISOTOPE ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION;

EID: 70350579264     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800111     Document Type: Article

References (35)

1. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Lavine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
2. Diamandis, E. P., Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 2004, 3, 367-378.
3. Check, E., Proteomics and cancer: running before we can walk? Nature 2004, 429, 496-497.
4. Ransohoff, D. F., Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 2005, 5, 142-149.
5. Sorace, J. M., Zhan, M., A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003, 4, 24.
6. Baggerly, K. A., Morris, J. S., Coombes, K. R., Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004, 20, 777-785.
7. Baggerly, K. A., Morris, J. S., Edmonson, S. R., Coombers, K. R., Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 2005, 97, 307-309.
8. Diamandis, E., Proteomic patterns to identify ovarian cancer: 3 years on. Expert Rev. Mol. Diagn. 2004, 4, 575-577.
9. Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D. et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002, 62, 3609-3614.
10. Semmes, O. J., Ziding, F., Adam, B. L., Banez L. L. et al., Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer. Clin. Chem. 2005, 51, 102-112.
11. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y. et al., Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48, 1296-1304.
12. Wadsworth, J. T., Somers, K. D., Cazares, L. H., Malik, G. et al., Serum protein profiles to identify head and neck cancer. Clin. Cancer Res. 2004, 10, 1625-1632.
13. Yang, S. Y., Xiao, X. Y., Zhang, W. G., Zhang L. J. et al., Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 2005, 5, 83.
14. Ward, D. G., Suggett, N., Cheng, Y., Wei, W. et al., Identification of serum biomarkers for colon cancer by proteomic analysis. Br. J. Cancer 2006, 94, 1898-1905.
15. Villanueva, J., Philip, J., Chaparro, C. A., Li, Y. et al., Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
16. Villanueva, J., Martorella, A. J., Lawlor, K., Philip, J. et al., Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol. Cell. Proteomics 2006, 5, 1840-1852.
17. Villanueva, J., Shaffer, D. R., Philip, J., Chaparro, C. A. et al., Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, 116, 271-284.
18. Koomen, J. M., Li, D., Xiao, L. C., Liu, T. C. et al., Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 2005, 4, 972-981.
19. Matrisian, L. M., Sledge, Jr. G. W., Mohla, S., Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Res. 2003, 63, 6105-6109.
20. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G. et al., NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6, 277-293.
21. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. B 1995, 57, 289-300.
22. Johnson, K. L., Mason, C. J., Muddiman, D. C., Eckel, J. E., Analysis of the low molecular weight fraction of serum by LC-Dual ESI-FT-ICR mass spectrometry: precision of retention time, mass, and ion abundance. Anal. Chem. 2004, 76, 5097-5103.
23. Crockford, D. J., Lindon J. C., Cloarec, O., Plumb, R. S. et al., Statistical search space reduction and two-dimensional data display approaches for UPLC-MS in biomarker discovery and pathway analysis. Anal. Chem. 2006, 78, 4398-4408.
24. Bergen, H. R., Vasmatzis, G., Cliby, W. A., Johnson K. L. et al., Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry. Dis. Markers 2003, 19, 239-249.
25. Ru, Q. C., Zhu, L. A., Silberman, J., Shriver, C. D., Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry. Mol. Cell. Proteomics 2006, 5, 1095-1104.
26. Baechle, D., Sparbier, K., Dihazi, H., Blaschke, S. et al., Towards stable diagnostic setups in clinical proteomics: absolute quantitation of peptide biomarkers using MALDI-TOF-MS. Proteomics Clin. Appl. 2007, 1, 1280-1284.
27. Barnidge, D. R., Goodmanson, M. K., Klee, G. G., Muddiman, D. C., Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J. Proteome Res. 2004, 3, 644-652.
28. Mayr, B. M., Kohlbacher, O., Reinert, K., Sturm, M. et al., Absolute myoglobin quantitation in serum by combining two-dimensional liquid chromatography-electrospray ionization mass spectrometry and novel data analysis algorithms. J. Proteome Res. 2006, 5, 414-421.
29. Roessler, M., Rollinger,W., Palme, S., Hagmann, M. L. et al., Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res. 2005, 11, 6550-6557.
30. Roessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M. L. et al., Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell. Proteomics 2006, 5, 2092-2101.
31. Albrethsen, J., Bogebo, R., Gammeltoft, S., Olsen, J. et al., Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 2005, 5, 8.
32. Chen, Y. D., Zheng, S., Yu, J. K., Hu, X., Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin. Cancer Res. 2004, 10, 8380-8385.
33. Yu, J. K., Zheng, S., Tang, Y., Li, L., An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J. Gastroenterol. 2004, 10, 3127-3131.
34. Semmes O. J., The omics Haystack: defining sources of sample bias in expression profiling. Clin. Chem. 2005, 51, 1571-1572.
35. Drake R. R., Cazares L., Semmes O. J., Mining the low molecular weight proteome of blood. Proteomics Clin. App. 2007, 1, 758-768.